{
    "nct_id": "NCT03824275",
    "official_title": "18F-DCFPyL Positron Emission Tomography (PET)/Computed Tomography (CT) in Men With Prostate Cancer",
    "inclusion_criteria": "1. Histologically confirmed diagnosis of prostate cancer\n2. PSA ≥ 0.2ng/ml\n3. Age ≥ 18 years of age\n4. Eastern Cooperative Oncology Group (ECOG) performance status ≤ 2 (karnofsky ≥ 60%)\n5. Ability to understand and willingness to sign a written informed consent document\n6. Wiling to comply with clinical trial instructions and requirements\n7. Willing to cover the cost of PyL PET/CT imaging if funds are not available\nHealthy volunteers allowed\nMust be MALE\nMust have minimum age of 18 Years",
    "exclusion_criteria": "1. History of another active malignancy within 3 years, other than basal cell and squamous cell carcinoma of the skin\n2. Presence of prostate brachytherapy implants unless approved by the PI\n3. Administration of another radioisotope within five physical half-lives of trial enrollment\n4. Radiation or chemotherapy within 2 weeks prior to trial enrollment\n5. Serum creatinine > 3 times the upper limit of normal\n6. Serum total bilirubin > 3 times the upper limit of normal\n7. Aspartate transaminase (AST) or alanine aminotransferase (ALT) >5 times the upper limit of normal\n8. Inadequate venous access",
    "miscellaneous_criteria": ""
}